Alnylam Pharmaceuticals, Inc. (ALNY) vs Genmab A/S Sponsored ADR (GMAB)

Alnylam Pharmaceuticals, Inc. and Genmab A/S Sponsored ADR are both Biotechnology companies. Alnylam Pharmaceuticals, Inc. is the larger, with a market value of $31.2B against $20.8B — 1.5× the size. Genmab A/S Sponsored ADR trades at the lower P/E: 27.8× against 43.6×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against 22.3%. Genmab A/S Sponsored ADR has the higher net margin (19.1% vs 16.1%) and the higher return on invested capital (6.99% vs 0.00%). Across the 21 metrics below, Genmab A/S Sponsored ADR leads on 11 and Alnylam Pharmaceuticals, Inc. on 10.